FAS and hematologic disorder: Mice lacking death-inducing molecule tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) [47], or with the inactivation of the Fas-mediated cell death pathway by Fas or FasL mutation, have accelerated hematological malignancies [48].